Holt is responsible for Cordis operations globally to develop and deliver innovative, life-saving treatments. He brings to the role more than 20 years of experience across all aspects of end-to-end commercialization in the healthcare industry.
Prior to assuming this role, Holt served as president of the Cardinal Health Medical segment in Asia Pacific where he led the expansion of Cardinal Health’s diversified medical products portfolio, including Cordis, the Patient Recovery business, Cardinal Health branded products and the Cardinal Health Inventory Management System (CIMS).
Previously, Holt held leadership positions of increasing responsibility at Allergan, including vice president and regional managing director of Asia. He also served as the company’s vice president and managing director for key markets including Greater China, Japan and Korea. Before joining Allergan, Holt spent over a decade at Merck where he held a series of leadership positions in Australia, Korea and Indonesia.
He earned a bachelor’s degree in biochemistry and chemistry from Monash University, Australia.